Lixte Biotechnology Holdings Inc. sell dimontalban
Start price
18.04.22
/
60%
€12.80
Target price
18.04.23
€0.000
Performance (%)
-41.80%
End price
02.06.22
€7.45
Summary
This prediction ended on 02.06.22 with a price of €7.45. dimontalban correctly predicted massive losses of -41.80% for Lixte Biotechnology Holdings Inc.. dimontalban has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Lixte Biotechnology Holdings Inc. | - | - | - |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to dimontalban what are the pros and cons of Lixte Biotechnology Holdings Inc. for the foreseeable future?
Pros
Good rating
Standard Investments for future growth
Growths faster than the competition
Known brand
Good culture
Small cyclical dependencies
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Risky balance sheet
ROE lower than 5% per year
Increased challenges to pay loans and raise capital
Below average Management
Little innovation
Few uniques
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Business model of the past or high risk
Dependend from some customers or products
Comments by dimontalban for this prediction
In the thread Lixte Biotechnology Hldgs Inc. diskutieren
Sell mit Kursziel 0,0